Recent Quotes
My Watchlist
Indicators
New Hampshire Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Rocket Pharmaceuticals, Inc. - Common Stock (NQ:RCKT)

2.990 -0.060 (-1.97%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,899,943
Open 3.050
Bid (Size) 3.010 (10)
Ask (Size) 3.120 (1)
Prev. Close 3.050
Today's Range 2.964 - 3.050
52wk Range 2.190 - 24.27
Shares Outstanding 65,837,894
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
August 11, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against RCKT
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
August 11, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against RCKT
Via TheNewswire.com
Topics Fraud Lawsuit

Performance

YTD
-76.5%
-76.5%
1 Month
+3.8%
+3.8%
3 Month
-62.7%
-62.7%
6 Month
-72.2%
-72.2%
1 Year
-86.5%
-86.5%

More News

Read More
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Rocket Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - RCKT
From Pomerantz LLP
Via GlobeNewswire
RCKT DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Rocket Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 11 Deadline in Securities Class Action – RCKT
From The Rosen Law Firm PA
Via GlobeNewswire
Rocket Pharmaceuticals, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - RCKT
Via NewMediaWire
Topics Fraud Lawsuit
Rocket Pharmaceuticals, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - RCKT
Via TheNewswire.com
Topics Fraud Lawsuit
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals
From Faruqi & Faruqi LLP
Via GlobeNewswire
What's Going On With Sarepta, Capricor And Other Gene Therapy Stocks On Wednesday?
Via Benzinga
Rocket Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before August 11, 2025 to Discuss Your Rights - RCKT
Via NewMediaWire
Topics Fraud Lawsuit
Rocket Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before August 11, 2025 to Discuss Your Rights - RCKT
Via TheNewswire.com
Topics Fraud Lawsuit
Investors in Rocket Pharmaceuticals, Inc. Should Contact Levi & Korsinsky Before August 11, 2025 to Discuss Your Rights - RCKT
Via NewMediaWire
Topics Fraud Lawsuit
Investors in Rocket Pharmaceuticals, Inc. Should Contact Levi & Korsinsky Before August 11, 2025 to Discuss Your Rights - RCKT
Via TheNewswire.com
Topics Fraud Lawsuit
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Rocket Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – RCKT
From The Rosen Law Firm PA
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Rocket Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - RCKT
From Pomerantz LLP
Via GlobeNewswire
Levi & Korsinsky Notifies Rocket Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - RCKT
Via NewMediaWire
Topics Fraud Lawsuit
Levi & Korsinsky Notifies Rocket Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - RCKT
Via TheNewswire.com
Topics Fraud Lawsuit
Rocket Refocuses Pipeline As Gene Therapy Sentiment Sours
Via Benzinga
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals
From Faruqi & Faruqi LLP
Via GlobeNewswire
Shareholders That Lost Money on Rocket Pharmaceuticals, Inc. (RCKT) Should Contact Levi & Korsinsky About Pending Class Action - RCKT
Via TheNewswire.com
Topics Fraud Lawsuit
Shareholders That Lost Money on Rocket Pharmaceuticals, Inc. (RCKT) Should Contact Levi & Korsinsky About Pending Class Action - RCKT
Via NewMediaWire
Topics Fraud Lawsuit
Rocket Pharmaceuticals, Inc. Class Action: Levi & Korsinsky Reminds Rocket Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of August 11, 2025 - RCKT
Via NewMediaWire
Topics Fraud Lawsuit
Rocket Pharmaceuticals, Inc. Class Action: Levi & Korsinsky Reminds Rocket Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of August 11, 2025 - RCKT
Via TheNewswire.com
Topics Fraud Lawsuit
Rocket Pharmaceuticals Announces Strategic Corporate Reorganization and Pipeline Prioritization of Cardiovascular Programs
From Rocket Pharmaceuticals, Inc.
Via Business Wire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Rocket Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - RCKT
From Pomerantz LLP
Via GlobeNewswire
Class Action Filed Against Rocket Pharmaceuticals, Inc. (RCKT) Seeking Recovery for Investors - Contact Levi & Korsinsky
Via TheNewswire.com
Topics Fraud Lawsuit

Frequently Asked Questions

Is Rocket Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Rocket Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Rocket Pharmaceuticals, Inc. - Common Stock trade on?
Rocket Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Rocket Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Rocket Pharmaceuticals, Inc. - Common Stock is RCKT on the Nasdaq Stock Market
What is the current price of Rocket Pharmaceuticals, Inc. - Common Stock?
The current price of Rocket Pharmaceuticals, Inc. - Common Stock is 2.990
When was Rocket Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Rocket Pharmaceuticals, Inc. - Common Stock was at 08/01/25 04:00 PM ET
What is the market capitalization of Rocket Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Rocket Pharmaceuticals, Inc. - Common Stock is 196.86M
How many shares of Rocket Pharmaceuticals, Inc. - Common Stock are outstanding?
Rocket Pharmaceuticals, Inc. - Common Stock has 197M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.